News Focus
News Focus
Followers 1177
Posts 134793
Boards Moderated 3
Alias Born 08/27/2003

Re: None

Tuesday, 12/09/2008 9:55:42 AM

Tuesday, December 09, 2008 9:55:42 AM

Post# of 5943
REPR -- profitable, rapidly growing, recession-proof, tiny float...

(1) After turning the corner of profitability a couple of quarters ago, sales and net income are starting to blow up:
http://biz.yahoo.com/e/081015/repr.ob10-q.html

(2) Expecting their quarterly performance to accelerate:
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=32890792
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=32890827

(3) Tiny market cap, shares outstanding, and float.
http://finance.yahoo.com/q/ks?s=REPR.OB

(4) Products are recession-proof with no direct competition with sales rapidly expanding due to a new treatment (Vivaglobin) where their infusion pump is the best, cheapest, safest, and most convenient form of delivery:
http://investorshub.advfn.com/boards/read_msg.asp?message_id=28775119
http://investorshub.advfn.com/boards/read_msg.asp?message_id=28777209
http://investorshub.advfn.com/boards/read_msg.asp?message_id=28838178

(5) They are hiring like crazy:
http://www.rmsmedicalproducts.com/Careers.htm
http://investorshub.advfn.com/boards/read_msg.asp?message_id=24616830

(6) Medicare reimbursement for the Freedom60 (their biggest & most exciting revenue-generating product) was increased 20 fold in June of 2007 and is the ONLY infusion pump accepted by Medicare for reimbursement for Subcutaneous Immune Globulin treatment (Vivaglobin):
http://investorshub.advfn.com/boards/read_msg.asp?message_id=28776642
http://investorshub.advfn.com/boards/read_msg.asp?message_id=28776847

(7) Additional products are being released this year as well as more products are in development.

Based on last Q, REPR is growing so fast with such large margins that I think they are 1 or 2 quarters away from +.02 EPS per quarter or more or an annualized +.08 EPS pace IMO. Possibly 2-3 quarters away from +.03 EPS per Q or an annualized +.12 EPS. A mere 15 PE with rapid recession-proof growth = $1.80/share.

More REPR INFO and Board:
http://investorshub.advfn.com/boards/board.aspx?board_id=201

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today